- Home
- DLPN vs RDHL Comparison
DLPN vs RDHL Comparison
Compare DLPN & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DLPN | RDHL |
|---|---|---|
| Founded | 1996 | 2009 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.8M | 5.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DLPN | RDHL |
|---|---|---|
| Price | $1.55 | $1.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 33.4K | ★ 71.8K |
| Earning Date | 11-12-2025 | 09-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $53,371,115.00 | $9,550,000.00 |
| Revenue This Year | $10.62 | $381.91 |
| Revenue Next Year | $13.78 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 3.86 | ★ 157.62 |
| 52 Week Low | $0.75 | $0.91 |
| 52 Week High | $1.88 | $6.80 |
Technical Indicators
Market Signals| Indicator | DLPN | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 54.30 | 38.43 |
| Support Level | $1.30 | $0.91 |
| Resistance Level | $1.63 | $1.23 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 80.00 | 46.21 |
Price Performance
Historical ComparisonAbout DLPN Dolphin Entertainment Inc.
Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.